Cargando…
Metastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines()
INTRODUCTION: Malignant pheochromocytoma represents 10% of all patients with pheochromocytoma. Of these cases, only 5–9% presents without elevation of metanephrines and catecholamines. PRESENTATION OF CASE: A 43-year-old female patient presented with an abdominal tumor. An exploratory laparotomy was...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099279/ https://www.ncbi.nlm.nih.gov/pubmed/27821293 http://dx.doi.org/10.1016/j.ijscr.2016.10.050 |
_version_ | 1782465936425484288 |
---|---|
author | López-Gómez, Javier Salazar-Álvarez, Ma. Alejandra Adame, Rodrigo Y. Alfaro-Goldaracena, Alejandro Flores-Vazquez, Erwin R. Gonzalez-Infante, Sergio H. Padilla-Rosciano, Alejandro E. López-Basave, Horacio N. |
author_facet | López-Gómez, Javier Salazar-Álvarez, Ma. Alejandra Adame, Rodrigo Y. Alfaro-Goldaracena, Alejandro Flores-Vazquez, Erwin R. Gonzalez-Infante, Sergio H. Padilla-Rosciano, Alejandro E. López-Basave, Horacio N. |
author_sort | López-Gómez, Javier |
collection | PubMed |
description | INTRODUCTION: Malignant pheochromocytoma represents 10% of all patients with pheochromocytoma. Of these cases, only 5–9% presents without elevation of metanephrines and catecholamines. PRESENTATION OF CASE: A 43-year-old female patient presented with an abdominal tumor. An exploratory laparotomy was performed and the final report was a pheochromocytoma. After ten years, multiple liver lesions were detected and surgical treatment was performed. Pathological evaluation revealed a malignant pheochromocytoma with negative margins after 5 years of follow-up without evidence of disease. DISCUSSION: The recurrence rate of malignant pheochromocytoma is 15–20% at ten years and a 5-year survival rate that ranges from 50% to 80%. The presence of synchronous metastases is rare (10–27%), but have been reported until 20 years later with the most common metastatic sites being the local lymph nodes, bone (50%), liver (50%) and lung (30%). The prognostic factor such as size >6 cm, age over 45 years, synchronous metastasis and no tumor excision are related with poor prognosis. CONCLUSION: Surgical treatment offers the best survival rate and the only chance of cure so far and the goal is an R0 resection as in our case. So it should be the treatment of choice. |
format | Online Article Text |
id | pubmed-5099279 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-50992792016-11-14 Metastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines() López-Gómez, Javier Salazar-Álvarez, Ma. Alejandra Adame, Rodrigo Y. Alfaro-Goldaracena, Alejandro Flores-Vazquez, Erwin R. Gonzalez-Infante, Sergio H. Padilla-Rosciano, Alejandro E. López-Basave, Horacio N. Int J Surg Case Rep Case Report INTRODUCTION: Malignant pheochromocytoma represents 10% of all patients with pheochromocytoma. Of these cases, only 5–9% presents without elevation of metanephrines and catecholamines. PRESENTATION OF CASE: A 43-year-old female patient presented with an abdominal tumor. An exploratory laparotomy was performed and the final report was a pheochromocytoma. After ten years, multiple liver lesions were detected and surgical treatment was performed. Pathological evaluation revealed a malignant pheochromocytoma with negative margins after 5 years of follow-up without evidence of disease. DISCUSSION: The recurrence rate of malignant pheochromocytoma is 15–20% at ten years and a 5-year survival rate that ranges from 50% to 80%. The presence of synchronous metastases is rare (10–27%), but have been reported until 20 years later with the most common metastatic sites being the local lymph nodes, bone (50%), liver (50%) and lung (30%). The prognostic factor such as size >6 cm, age over 45 years, synchronous metastasis and no tumor excision are related with poor prognosis. CONCLUSION: Surgical treatment offers the best survival rate and the only chance of cure so far and the goal is an R0 resection as in our case. So it should be the treatment of choice. Elsevier 2016-10-22 /pmc/articles/PMC5099279/ /pubmed/27821293 http://dx.doi.org/10.1016/j.ijscr.2016.10.050 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report López-Gómez, Javier Salazar-Álvarez, Ma. Alejandra Adame, Rodrigo Y. Alfaro-Goldaracena, Alejandro Flores-Vazquez, Erwin R. Gonzalez-Infante, Sergio H. Padilla-Rosciano, Alejandro E. López-Basave, Horacio N. Metastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines() |
title | Metastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines() |
title_full | Metastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines() |
title_fullStr | Metastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines() |
title_full_unstemmed | Metastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines() |
title_short | Metastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines() |
title_sort | metastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines() |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099279/ https://www.ncbi.nlm.nih.gov/pubmed/27821293 http://dx.doi.org/10.1016/j.ijscr.2016.10.050 |
work_keys_str_mv | AT lopezgomezjavier metastaticpheochromocytomatoliverwithoutelevationofmetanephrinesandcatecholamines AT salazaralvarezmaalejandra metastaticpheochromocytomatoliverwithoutelevationofmetanephrinesandcatecholamines AT adamerodrigoy metastaticpheochromocytomatoliverwithoutelevationofmetanephrinesandcatecholamines AT alfarogoldaracenaalejandro metastaticpheochromocytomatoliverwithoutelevationofmetanephrinesandcatecholamines AT floresvazquezerwinr metastaticpheochromocytomatoliverwithoutelevationofmetanephrinesandcatecholamines AT gonzalezinfantesergioh metastaticpheochromocytomatoliverwithoutelevationofmetanephrinesandcatecholamines AT padillaroscianoalejandroe metastaticpheochromocytomatoliverwithoutelevationofmetanephrinesandcatecholamines AT lopezbasavehoracion metastaticpheochromocytomatoliverwithoutelevationofmetanephrinesandcatecholamines |